Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) insider Brenna Mcgibney sold 5,000 shares of the firm’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.99, for a total value of $164,950.00. Following the sale, the insider now owns 3,738 shares of the company’s stock, valued at $123,316.62. This represents a 57.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Trupanion Price Performance
Shares of NASDAQ TRUP opened at $34.09 on Thursday. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $1.45 billion, a price-to-earnings ratio of -148.22, a price-to-earnings-growth ratio of 6.02 and a beta of 1.70. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90. The business has a 50 day simple moving average of $43.21 and a 200-day simple moving average of $47.24.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The business had revenue of $337.31 million for the quarter, compared to the consensus estimate of $335.41 million. As a group, equities research analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current year.
Institutional Investors Weigh In On Trupanion
Analyst Upgrades and Downgrades
A number of brokerages recently commented on TRUP. Piper Sandler lowered their price objective on Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research note on Thursday, February 20th. Stifel Nicolaus decreased their price target on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $46.60.
View Our Latest Stock Report on TRUP
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
- Five stocks we like better than Trupanion
- What is the S&P/TSX Index?
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Energy and Oil Stocks Explained
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.